Multicenter, open-label trial to assess the safety and tolerability of drospirenone 4.0  mg over 6 cycles in female adolescents, with a 7-cycle extension phase

To assess the safety, tolerability and bleeding patterns of drospirenone 4.0  mg.
Source: Contraception - Category: OBGYN Authors: Tags: Original Research Article Source Type: research
More News: Bleeding | OBGYN